Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

To be able to join this study, you would generally need to be a man or woman who is 46 years old or older. You must have been diagnosed with a specific type of glaucoma called primary open-angle glaucoma. This means you have glaucoma and your doctor has discussed treatments with you, such as eye drops, laser treatment, or even surgery.

Another important point is that you must have already had cataract surgery in the eye being studied, and that surgery should have been straightforward and without complications. This means your eye already has an artificial lens.

There are also some reasons why you might not be able to join. For example, if you have other types of glaucoma like angle-closure, congenital (from birth), or secondary glaucoma. You also can't have other serious eye conditions that affect your vision, or any current infection or inflammation in your eye.

Taking part in this study would involve several visits to the clinic over time. During these visits, doctors and nurses will carry out various examinations to check your eye health, measure your eye pressure, and see how the implant is working. They will also ask you about your vision and any symptoms you might have. You might need to have your vision tested, and your eyes checked using special equipment.

The MINIject™ implant is a device that would be placed in your eye during a small surgical procedure. After the procedure, there will be a follow-up period where your eye will be monitored regularly. You might be asked to use eye drops or other medications as directed by the study doctors. The total time you would be involved in the study will depend on the study design, but generally, clinical trials involve monitoring for months, or sometimes even longer, to properly assess the effects of a new treatment. All these steps are important to make sure the implant is safe and effective.